Deferred Tax Assets, Valuation Allowance in USD of Cardiff Oncology, Inc. from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cardiff Oncology, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2013 to Q4 2024.
  • Cardiff Oncology, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $48,434,000, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Cardiff Oncology, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $48,434,000 +$9,263,000 +24% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q4 2023 $39,171,000 +$9,089,000 +30% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $30,082,000 +$8,249,000 +38% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $21,833,000 -$26,122,000 -54% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q4 2020 $47,955,000 +$4,134,000 +9.4% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $43,821,000 +$40,087,000 +1074% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $3,734,000 -$9,219,000 -71% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $12,953,000 -$3,639,000 -22% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $16,592,000 +$5,248,000 +46% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q4 2015 $11,344,000 +$5,244,000 +86% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $6,100,000 +$1,701,000 +39% 31 Dec 2014 10-K 15 Mar 2017 2016 FY
Q4 2013 $4,399,000 31 Dec 2013 10-K 10 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.